Ann‐Charlotte Kristoffersson

Immunology and Microbiology · Life Sciences

22h-index1.6kcitations55works1.22yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complement system in diseases(32), Platelet Disorders and Treatments(15), Renal Diseases and Glomerulopathies(14), Blood groups and transfusion(13), Escherichia coli research studies(8)

Publications55 total

Cellular signaling pathway of Shiga toxin-induced ATP release
Frontiers in Cellular and Infection Microbiology·2026Open Access
Angiotensinogen and C3 compete for renin-induced complement activation
Frontiers in Immunology·2025· 2 citedOpen Access
Bradykinin B1 receptor signaling triggers complement activation on endothelial cells
Frontiers in Immunology·2025· 1 citedOpen Access
Corrigendum: Genetic investigation of Nordic patients with complement-mediated kidney diseases
Frontiers in Immunology·2024Open Access
Hypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone
Clinical Kidney Journal·2024Open Access
Red blood cell-derived arginase release in hemolytic uremic syndrome
Journal of Translational Medicine·2024· 4 citedOpen Access
Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome
Pediatric Nephrology·2023· 1 citedOpen Access
Genetic investigation of Nordic patients with complement-mediated kidney diseases
Frontiers in Immunology·2023· 6 citedOpen Access
Genetic investigation of Nordic patients with complement-mediated kidney diseases
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome
Kidney International Reports·2023· 1 citedOpen Access
Apyrase decreases phage induction and Shiga toxin release from <i>E. coli</i> O157:H7 and has a protective effect during infection
Gut Microbes·2022· 17 citedOpen Access
IgG Binds Escherichia coli Serine Protease EspP and Protects Mice From E. coli O157:H7 Infection
Frontiers in Immunology·2022· 7 citedOpen Access
Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis
Frontiers in Immunology·2021· 17 citedOpen Access
Shiga Toxin-Bearing Microvesicles Exert a Cytotoxic Effect on Recipient Cells Only When the Cells Express the Toxin Receptor
Frontiers in Cellular and Infection Microbiology·2020· 19 citedOpen Access
A clinical trial comparing aliskiren with enalapril for the treatment of C3 glomerulopathy
The Journal of Immunology·2020
Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism
Scientific Reports·2019· 20 citedOpen Access
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
EBioMedicine·2019· 38 citedOpen Access
Table of Contents
Kidney International·2018Open Access
Aliskiren inhibits renin-mediated complement activation
Kidney International·2018· 72 cited
C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles
Journal of the American Society of Nephrology·2017· 36 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Diana Karpman(40), Anne-lie Ståhl(12), Lars Holmberg(12), Ida Arvidsson(10), Ramesh Tati(9), Karl Johansson(6), Johan Rebetz(6), Zivile Békássy(6), Ashmita Tontanahal(6), Sigridur Sunna Aradottir(6), Sebastian Loos(5), Véronique Frémeaux‐Bacchi(5), Fariba Vaziri‐Sani(4), Matthias Mörgelin(4), Anders I. Olin(4), Milan Chromek(3), Minola Manea(3), Lisa Sartz(3), Maria Mossberg(3), Robin Kahn(3)